I don’t have live access to current news feeds right now. Here’s how you can get the latest specifically for Novo Nordisk A/S at Bagsværd (NN1):
- Check Novo Nordisk’s official newsroom for latest press releases and site-specific updates. Their Newsroom is the primary source for authoritative statements and facility-related news.[9][10]
- Look for site-location notes in press releases about Bagsværd or NN1, as some updates are announced in the context of production capacity, investments, or site expansions. Globenewswire and Ritzau translations often carry such details when a Danish site is involved.[4][5]
- For corroborating media coverage, search industry press (chemanager-online, GlobeNewswire) for any recent facility investments or site acquisitions tied to NN1, since production expansions and strategic site moves are common news around Bagsværd.[2][3]
If you’d like, I can summarize the latest items from those sources once you confirm you want me to fetch and compile them for you. I can also pull direct links to the most recent NN1-related headlines and any corresponding press releases.
Sources
Get the latest Novo Nordisk A/S (NOVO-B) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
www.google.comBagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production...
www.globenewswire.comDec. 16, 2024 14:29
www.taiwannews.com.twNovo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
via.ritzau.dkestablishing a new production site. The new site will feature a state-of-the-art finished production facility and warehouse spanning over 40,000 m2. Designed to be modular and flexible, it will accommodate multiple product types within rare disease, such as haemophilia, both now and in the future.
via.ritzau.dkHere journalists can access a concise and up-to-date overview of our company’s key facts, figures, and milestones.
www.novonordisk.comNovo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
via.ritzau.dkDanish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark. News … Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production...
chemanager-online.com